Global Deafness Gene Detection Kits Market Size To Worth USD 0.315 Billion By 2033 | CAGR of 4.04%
Category: HealthcareGlobal Deafness Gene Detection Kits Market Size To Worth USD 0.315 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Deafness Gene Detection Kits Market Size is Expected to Grow from USD 0.212 Billion in 2023 to USD 0.315 Billion By 2033, at a CAGR of 4.04% during the Forecast Period 2023-2033
Get more details on this report -
Browse key industry insights spread across 220 pages with 120 Market data tables and figures & charts from the report on the "Global Deafness Gene Detection Kits Market Size, Share, and COVID-19 Impact Analysis, By Type (Real-Time PCR, Microarray Chip Method, and Others), By Application (Adult Detection and Newborn Detection), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/deafness-gene-detection-kits-market
The deafness gene detection kits market focuses on diagnostic tools for identifying genetic mutations linked to hearing loss or deafness. The Hearing Loss Susceptibility Geno Array Diagnostic Kit is a high-throughput screening tool for hotspot mutations in four genes, enabling early diagnosis and prevention of certain antibiotics. In China, 27.8 million people have hearing disabilities, with over 30,000 new deaf children born each year. Over 80 million people are affected by environmental factors, unknown factors, and deaf gene mutations. Traditional detection methods cannot detect deafness caused by late deafness or gene mutations in time, making testing crucial for early diagnosis, detection, and intervention. The World Health Organization reports that over 430 million people, including 34 million children, need rehabilitation to treat debilitating hearing loss, with projections of over 700 million people suffering by 2050. Hearing loss, a common sensory deficit worldwide is increasing due to factors like aging populations, noise pollution, and unsafe listening practices. Gene therapy is a promising cure, especially for inherited variants, which make up over 50% of cases. Advances in genetic research are driving the demand for advanced gene detection kits. However, higher prices of kits may impede the growth of the market.
The real-time PCR segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the type, the global deafness gene detection kits market is categorized as real-time PCR, microarray chip method, and others. Among these, the real-time PCR segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. The segment's growth is attributed to its reduced errors, faster, sensitive, specific, precise PCR product assessment, lower targeted DNA or RNA concentration, reproducibility, and ease of handling.
The newborn detection segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the application, the global deafness gene detection kits market is categorized as adult detection and newborn detection. Among these, the newborn detection segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. This is attributed to early diagnosis, and technological innovations, and provides particular insights regarding the cause of deafness, the rising prevalence of hearing loss in neonates and infants, and genetic mutations.
North America is expected to hold the greatest share of the global deafness gene detection kits market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global deafness gene detection kits market over the forecast period. The US market, a significant market in North America with a high prevalence of genetic hearing loss, is experiencing growth due to its robust healthcare infrastructure, advanced diagnostic technologies, favorable reimbursement policies, research and development activities, and the presence of major market players. The utilization of deafness gene detection kits is expected to be boosted by active market participation and favorable reimbursement policies.
Asia Pacific is predicted to grow at the fastest CAGR throughout the estimated period. Hereditary diseases are gaining popularity due to increased awareness and medical costs. China, Japan, and India are major markets in this region. Government initiatives, expanding medical facilities, and economic growth are driving the sector's expansion. This presents opportunities for market participants to reduce their environmental impact and capitalize on the growing demand for genetic testing products.
Major key players in the global deafness gene detection kits market are Centogene N.V., Thermo Fisher Scientific Inc., PerkinElmer, Inc., Agilent Technologies, Inc., Myriad Genetics, Inc., Bio-Rad Laboratories, Inc., Pacific Biosciences of California, Inc., Genomic Vision, Invitae Corporation, Illumina, Inc., Becton, Dickinson and Company, Natera, Inc., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In July 2024, Genedrive plc, a pharmacogenetic testing company, received Breakthrough Device Designation from the U.S. Food and Drug Administration for its MT-RNR1 ID Kit. This rapid point-of-care test screens infants for a genetic variant that can cause life-long hearing loss when given certain antibiotics. Infants identified with the variant can be given alternative antibiotics, potentially saving thousands of children from hearing loss and providing a net positive financial outcome case to healthcare systems.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global deafness gene detection kits market based on the below-mentioned segments:
Global Deafness Gene Detection Kits Market, By Type
- Real-Time PCR
- Microarray Chip Method
- Others
Global Deafness Gene Detection Kits Market, By Application
- Adult Detection
- Newborn Detection
Global Deafness Gene Detection Kits Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?